Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
2 weeks ago • Google News
Voyager Therapeutics Inc (VYGR)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 206.9M
P/E Ratio
0.00
Revenue (TTM)
$ 42.58M
Volume
0
52W High
$ 8.28
52W Low
$ 2.65
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
3.2588
200-Day MA
4.3517
52 Week High
8.28
52 Week Low
2.65
About VYGR
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases.
Employees
172
Headquarters
Lexington, MA
CEO
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.